0001193805-24-000767.txt : 20240607 0001193805-24-000767.hdr.sgml : 20240607 20240607160534 ACCESSION NUMBER: 0001193805-24-000767 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Errico Thomas J. CENTRAL INDEX KEY: 0001737633 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38538 FILM NUMBER: 241029310 MAIL ADDRESS: STREET 1: 150 ALLEN ROAD, SUITE 201 CITY: BASKING RIDGE STATE: NJ ZIP: 97920 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: electroCore, Inc. CENTRAL INDEX KEY: 0001560258 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 203454976 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 FORGE WAY STREET 2: SUITE 205 CITY: ROCKAWAY STATE: NJ ZIP: 07866 BUSINESS PHONE: 973-290-0097 MAIL ADDRESS: STREET 1: 200 FORGE WAY STREET 2: SUITE 205 CITY: ROCKAWAY STATE: NJ ZIP: 07866 FORMER COMPANY: FORMER CONFORMED NAME: ElectroCore, LLC DATE OF NAME CHANGE: 20121012 4 1 e663689_4-errico.xml X0508 4 2024-06-05 0 0001560258 electroCore, Inc. ECOR 0001737633 Errico Thomas J. 200 FORGE WAY, SUITE 205 ROCKAWAY NJ 07866 1 0 0 0 0 Common Stock 2024-06-05 4 A 0 38505 6.43 A 228818 D Warrants to Purchase Common Stock 6.43 2024-06-05 4 P 0 19252 0.0625 A 2024-06-05 2029-06-05 Common Stock 19252 19252 D On June 5, 2024, pursuant to a private placement offering by the Issuer, the Reporting Person acquired 38,505 Units, each Unit consisting of (i) one share of the Issuer's Common Stock and (ii) one Warrant to purchase one-half share of the Issuer's Common Stock. The combined purchase price in the Offering was $6.4925 per Unit, inclusive of $6.43 per share of Common Stock and $0.0625 per Warrant. Each Warrant entitles the holder thereof to purchase one half of a share of Common Stock, is immediately exercisable from the date of issuance at an exercise price of $6.43 per share, and expires five years after issuance. Consists of 192,051 shares of common stock beneficially owned directly by the Reporting Person; 1,296 shares of common stock beneficially owned by a trust for the benefit of the Reporting Person's family members; and includes 31,848 shares that have vested pursuant to previously issued Deferred Stock Units, and 3,623 of such shares will vest through August 4, 2024, provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date. All such vested and unvested shares were previously reported on Form 4 filings at the time of grant. /s/ John L. Cleary, II, attorney-in-fact 2024-06-07